Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement
BioFactors · 2024-11 · 50 (6) · 1192-1207
DOI: 10.1002/biof.2077 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 22.05.2024. Verfasst von Tomoya Ueda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 1, Phthalic Anhydrides, MAP Kinase Signaling System, Fibroblasts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Drug‐induced gingival enlargement (DIGE) is a side effect of ciclosporin, calcium channel blockers, and phenytoin. DIGE is a serious disease that leads to masticatory and esthetic disorders, severe caries, and periodontitis but currently has no standard treatment. We recently reported that nuclear receptor 4A1 (NR4A1) is a potential therapeutic target for DIGE. This study aimed to evaluate the therapeutic effects of n ‐butylidenephthalide (BP), which increases the expression of NR4A1, on DIGE. In this study, NR4A1 mRNA expression was analyzed in the patients with periodontal disease (PD) and DIGE. We evaluated the effect of BP on NR4A1 expression in gingival fibroblasts and in a DIGE mouse model. RNA sequencing (RNA‐seq) was conducted to identify the mechanisms by which BP increases NR4A1 expression. The results showed that NR4A1 mRNA expression in the patients with DIGE was significantly lower than the patients with PD. BP suppressed the upregulation of COL1A1 expression, which was upregulated by TGF‐β. BP also ameliorated gingival overgrowth in DIGE mice and reduced Col1a1 and Pai1 expression. BP also decreased Il1β mRNA expression in gingival tissue in DIGE. RNA‐seq results showed an increase in the expression of several genes related to mitogen‐activated protein kinase including DUSP genes in gingival fibroblasts stimulated by BP. Treatment with ERK and JNK inhibitors suppressed the BP‐induced increase in NR4A1 expression. In addition, BP promoted the phosphorylation of ERK in gingival fibroblasts. In conclusion, BP increases NR4A1 expression in gingival fibroblasts through ERK and JNK signaling, demonstrating its potential as a preventive and therapeutic agent against DIGE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Oral Science and Translation Research, College of Dental Medicine, Nova Southeastern University, Fort Lauderdale, Florida, USA.
- Center of Oral Clinical Examination, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
ORCID-Profile: Shinji Matsuda
Förderung
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Ueda, T., Matsuda, S., Ninomiya, Y., Nakashima, F., Yasuda, K., Furutama, D., Memida, T., Yoshimoto, T., Kajiya, M., Ohta, K., Ouhara, K., & Mizuno, N. (2024). Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement. BioFactors, 50(6), 1192-1207. https://doi.org/10.1002/biof.2077
Vancouver
Ueda T, Matsuda S, Ninomiya Y, Nakashima F, Yasuda K, Furutama D, et al. Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement. BioFactors. 2024;50(6):1192-1207. doi:10.1002/biof.2077
BibTeX
@article{Ueda2024,
author = {Ueda, Tomoya and Matsuda, Shinji and Ninomiya, Yurika and Nakashima, Fuminori and Yasuda, Keisuke and Furutama, Daisuke and Memida, Takumi and Yoshimoto, Tetsuya and Kajiya, Mikihito and Ohta, Kouji and Ouhara, Kazuhisa and Mizuno, Noriyoshi},
title = {Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement},
journal = {BioFactors},
year = {2024},
volume = {50},
number = {6},
pages = {1192--1207},
doi = {10.1002/biof.2077}
}
EUVIMED